维生素D及其受体在帕金森病中的作用

帕金森病(Parkinson's disease,PD)是一种常见的中枢神经系统退行性疾病,引起帕金森病的发病机制至今尚未明确。帕金森病患者及老年人普遍存在维生素D缺乏,这可能是帕金森病的重要发病机制之一。由于维生素D具有免疫调节,抗氧化,调节神经营养因子,降低神经毒性的功能,能同时针对几种导致神经退行性病变因素发挥作用,特别是老年人纠正维生素D缺乏可能会阻止神经元的损失和PD相关的认知功能下降。因此补充维生素D可能成为治疗PD的方法。近年来研究发现,维生素D受体基因多态性与帕金森病的发病有相关性。该文就维生素D及其受体在帕金森病中可能发生的保护作用及其机制作一综述。     

补充维生素D对小鼠发育行为的影响研究

目的:本研究通过对子代小鼠维生素D的干预,探讨维生素D对子代小鼠行为的重要影响,为孕期补充维生素D提供理论依据。方法:建立孕鼠维生素D缺乏的实验模型。将子代小鼠分为三组:肌注维生素D的低剂量饮食组(a组,补充组)、肌注生理盐水的低剂量饮食组(b组,缺乏组)和正常饮食组(c组)。在第24天和第60天时,采用旷场实验、Morris水迷宫实验、社交试验对子代小鼠的行为进行监测。结果:孕期维生素D缺乏对子代小鼠的维生素D水平有显著的影响,子代小鼠出生10天时血清维生素D的浓度分别为:低剂量饮食组12.98±0.65μg/L,正常饮食组35.38±1.13μg/L,两组浓度值差异显著(P0.05)。旷场实验中,第24天时,缺乏组子代小鼠的运动总路程为1044±89.21 cm,显著少于补充组(1701.56±150.5 cm)和正常组(1755±154.2 cm),而其在中央区停留的时间为34.84±3.54 s,显著高于补充组(21.36±3.05 s)和正常组(21.77±3.64 s),其在周边停留的时间为265.2±3.54 s,显著少于补充组(278.6±3.05 s)和正常组(278.2±3.64 s);第60天时缺乏组子代小鼠在中央区停留的时间为28.79±3.68 s,显著高于补充组(17.21±2.59 s)和正常组(18.37±1.99 s),其在周边停留的时间为271.2±3.68 s,显著少于补充组(282.7±2.54 s)和正常组(281.6±1.99 s)。缺乏组在第60天时行动总路程为1653±141 cm低于其他两组,但差异不显著。Morris水迷宫实验中,三组子代小鼠第24天的穿越次数均显著高于第60天,呈现先增加后降低的趋势,而缺乏组的降低趋势更为明显。平台停留时间方面,三组子代小鼠在第60天均多于第24天,呈增加趋势。社交实验中,第24天时三组小鼠探索空笼子的时间没有明显差异,但缺乏组小鼠与代表新伙伴的陌生鼠1接触的时间低于与空笼子的接触时间,而正常组和补充组小鼠与陌生鼠接触的时间明显多于空笼子。第60天时三组小鼠探索空笼子的时间也没有明显差异,虽然缺乏组小鼠与陌生鼠的接触时间略高于与空笼子的接触时间,但差异不显著,而正常组和补充组小鼠与陌生鼠接触的时间仍明显多于空笼子。结论:向维生素D缺乏的子代小鼠补充维生素D能够对子代小鼠的兴奋性、空间认知能力、学习记忆能力和社交行为产生良性影响,在发育早期进行维生素D补充具有重要的预防作用。     

孕妇体内维生素D含量与新生儿湿疹的相关性

目的:研究孕妇维生素D(25(OH)D)含量与新生儿湿疹的关系,为改善孕期维生素D缺乏,预防婴儿湿疹提供临床依据。方法:选取2013年9月-2013年11月在我院生产的孕妇及所生的新生儿,调查研究对象的基本情况。采集孕妇的静脉血进行25(OH)D含量测定,并诊断新生儿湿疹的发生情况。结果:孕妇25(OH)D含量的中位数是15.17 ng/m L,新生儿湿疹的发病率是26.1%。孕妇不同含量25(OH)D水平与孕中晚期补充复合维生素、服用奶制品、摄入鱼蛋类次数、每天晒太阳时间等有关(P0.05);孕妇25(OH)D含量20 ng/m L会增加子女6个月内患湿疹的风险(OR=3.19,95%;CI:1.54,4.21)。结论:孕妇25(OH)D含量缺乏会增加新生儿湿疹的发病率。     

Altered downstream target gene expression of the placental Vitamin D receptor in human idiopathic fetal growth restriction

Fetal growth restriction (FGR) affects up to 5% of pregnancies and is associated with significant perinatal complications. Maternal deficiency of vitamin D, a secosteroid hormone, is common in FGR-affected pregnancies. We recently demonstrated that decreased expression of the vitamin D receptor (VDR) in idiopathic FGR placentae could impair trophoblast growth. As strict regulation of cell-cycle genes in trophoblast cells is critical for optimal feto-placental growth, we hypothesised that pathologically decreased placental VDR contributes to aberrant regulation of cell-cycle genes. The study aims were to (i) identify the downstream cell-cycle regulatory genes of VDR in trophoblast cells, and (ii) determine if expression was changed in cases of FGR. Targeted cell-cycle gene cDNA arrays were used to screen for downstream targets of VDR in VDR siRNA-transfected BeWo and HTR-8/SVneo trophoblast-derived cell lines, and in third trimester placentae from FGR and gestation-matched control pregnancies (n = 25 each). The six candidate genes identified were CDKN2A, CDKN2D, HDAC4, HDAC6, TGFB2 and TGFB3. TGFB3 was prioritised for further validation, as its expression is largely unknown in FGR. Significantly reduced mRNA and protein expression of TGFB3 was verified in FGR placentae and the BeWo and HTR-8/SVneo trophoblast cell lines, using real-time PCR and immunoblotting respectively. In summary, decreased placental VDR expression alters the expression of regulatory cell-cycle genes in FGR placentae. Aberrant regulation of cell-cycle genes in the placental trophoblast cells may constitute a mechanistic pathway by which decreased placental VDR reduces feto-placental growth.     

KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male

Gastric cancer is one of the top causes of cancer-related death around the world, and poor prognosis of gastric cancer is due to the lack of early detection and effective treatment especially in male. Here, we first revealed the role of histone lysine-specific demethylase 5D (KDM5D) in gastric cancer in male. KDM5D was associated with the metastasis of gastric cancer because of its critical role in the epithelial-mesenchymal transition of gastric cancer cells. Downregulation of KDM5D in gastric cancer cells significantly increase the number of migrated or invaded cells due to the increasing expressions of mesenchymal markers. Downregulation of KDM5D also promotes tumor formation of gastric cancer cell in vivo. For mechanism, downregulation of KDM5D could inhibit the demethylation in the promoter of CUL4A, which lead to the increasing expression of ZEB1 and decreasing expressions of p21 and p53. Collectively, KDM5D performed its role in metastasis of gastric cancer through demethylation in the promoter of CUL4A, and it suggested us a novel target in gastric cancer treatment in male.     

中国北方地区血清钙、维生素D水平与乳腺癌的相关性研究

目的:探讨中国北方地区血清钙、维生素D水平与乳腺癌及相关临床因素的关系.方法:选取2007年12月至2012年7月哈尔滨医科大学附属肿瘤医院794例女性乳腺癌患者及976例乳腺良性肿瘤患者,并以128例健康妇女为对照,取空腹血清采用原子吸收分光光度法检测三组血清钙含量,采用放免法检测三组中162例血清25(OH)D含量,结合相关临床资料进行分析.结果:乳腺癌组血清钙含量为2.26± 0.12 mmol/L,乳腺良性肿瘤组血清钙含量为2.26±0.09 mmol/L,正常对照组血清钙含量为2.25±0.24 mmol/L,经方差分析,三组总体均数差别无统计学意义(P＞0.05);乳腺癌患者的血清钙水平与年龄、TNM分期、BMI、绝经情况、乳腺癌家族遗传史无关(P＞0.05).乳腺癌组血清25(OH)D含量为41.91±7.55 ng/mL,乳腺良性肿瘤血清25(OH)D含量为54.62±7.48 ng/mL,正常对照组血清25(OH)D含量为56.15±8.87 ng/mL,经方差分析,乳腺癌患者血清25(OH)D含量低于乳腺良性肿瘤组,差别有统计学意义(P＜0.05),乳腺良性肿瘤组与正常对照组差别无统计学意义(P＞0.05);乳腺癌患者的维生素D水平与年龄、TNM分期、BMI、绝经情况有关(P＜0.05),而与乳腺癌家族遗传史无关(P＞0.05).结论:中国北方地区的乳腺癌患者血清钙水平与乳腺良性肿瘤患者无明显差异.乳腺癌患者的维生素D水平低于乳腺良性肿瘤患者,并且与年龄、TNM分期、BMI、绝经情况有关.维生素D水平降低可能与乳腺癌的发生有关,高水平的维生素D可能会降低女性患乳癌的风险.     

细胞色素P450 3A7羟化维生素D3的功能研究

本研究通过体外生化实验研究细胞色素P450 3A7对维生素D3的羟化作用。根据GenBank报道的序列设计特异引物,扩增cyp3a7的编码区,将cyp3a7的编码区插入到pcDNATM3.1/myc-His(-) A的XhoⅠ/Bam HⅠ,通过测序检测序列的正确性。pcDNA-CYP3A7及pcDNA分别瞬时转染293T细胞,48 h后收集细胞,提取S9组分,用Bradford法测定蛋白质浓度。S9组分经12%SDS-PAGE凝胶电泳和Western blotting检测,用myc抗体作为一抗检测CYP3A7在293T细胞的表达水平。0.6 mg S9组分与1μmol/L维生素D3于37℃孵育30 min,用4倍体积的氯仿甲醇(体积比为3∶1)抽提,有机相在氮气流下吹干,残基用于HPLC分析。结果显示,重组表达CYP3A7的293T细胞的S9组分通过Western blotting检测到了特异的约60 kD的条带,对照样品未检测到特异条带的蛋白质。重组表达CYP3A7的293T细胞S9组分的孵育样品通过HPLC检测到了25-羟基维生素D3,对照样品未检测到25-羟基维生素D3。结果表明重组表达的CYP3A7羟化维生素D3生成25-羟基维生素D3。本研究为进一步探究还有哪些P450参与维生素D3在鸡体内的代谢,为阐明其代谢途径提供理论依据。     

Vitamin D status and its modulatory effect on interferon gamma and interleukin-10 production by peripheral blood mononuclear cells in culture

ObjectivesWe aimed to investigate the influence of vitamin D on the production of the pro-inflammatory cytokine, interferon gamma (IFN-γ), and the anti-inflammatory cytokine, interleukin-10 (IL-10), in peripheral blood mononuclear cell (PBMC) cultures.MethodsThirty healthy subjects were investigated. Serum levels of calcium, 25(OH) D, and parathyroid hormone (PTH) were assessed. PBMCs were activated in-vitro by phytohemagglutinin (PHA) in the presence and absence of vitamin D3 and then levels of IFN-γ and IL-10 were determined in culture supernatant using enzyme immunoassay.ResultsSerum calcium levels were significantly lower in the vitamin D deficient group while serum PTH levels were significantly higher in the vitamin D deficient group. PTH levels were inversely correlated to both calcium and 25(OH) D levels. In culture, vitamin D inhibited IFN-γ production and increased IL-10 production by PBMCs. Serum vitamin D status had no influence on the amount of cytokine produced in culture.ConclusionsThis study demonstrates that vitamin D modulates IFN-γ and IL-10 production and provides a rationale for evaluating vitamin D as an immunomodulatory agent.     

Real-life use of vitamin D3-fortified bread and milk during a winter season: the effects of CYP2R1 and GC genes on 25-hydroxyvitamin D concentrations in Danish families,the VitmaD study

Common genetic variants rs10741657 and rs10766197 in CYP2R1 and rs4588 and rs842999 in GC and a combined genetic risk score (GRS) of these four variants influence late summer 25-hydroxyvitamin D (25(OH)D) concentrations. The objectives were to identify those who are most at risk of developing low vitamin D status during winter and to assess whether vitamin D₃-fortified bread and milk will increase 25(OH)D concentrations in those with genetically determined low 25(OH)D concentrations at late summer. We used data from the VitmaD study. Participants were allocated to either vitamin D₃-fortified bread and milk or non-fortified bread and milk during winter. In the fortification group, CYP2R1 (rs10741657) and GC (rs4588 and rs842999) were statistically significantly associated with winter 25(OH)D concentrations and CYP2R1 (rs10766197) was borderline significant. There was a negative linear trend between 25(OH)D concentrations and carriage of 0–8 risk alleles (p < 0.0001). No association was found for the control group (p = 0.1428). There was a significant positive linear relationship between different quintiles of total vitamin D intake and the increase in 25(OH)D concentrations among carriers of 0–2 (p = 0.0012), 3 (p = 0.0001), 4 (p = 0.0118) or 5 (p = 0.0029) risk alleles, but not among carriers of 6–8 risk alleles (p = 0.1051). Carriers of a high GRS were more prone to be vitamin D deficient compared to carriers of a low GRS. Furthermore, rs4588-AA carriers have a low but very stable 25(OH)D concentration, and interestingly, also low PTH level.

Electronic supplementary material

The online version of this article (doi:10.1007/s12263-014-0413-7) contains supplementary material, which is available to authorized users.     

Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer

1,25-Dihydroxyvitamin D₃ (1,25(OH)₂D₃) interacts with the Vitamin D₃ receptor (VDR) to modulate proliferation and apoptosis in a variety of cell types, including breast cancer cells. In this review, we discuss three issues related to the role of the VDR in growth control: first, whether mammary glands lacking VDR exhibit abnormal growth; second, whether the VDR is essential for induction of apoptosis by 1,25(OH)₂D₃; and third, whether VDR up-regulation can sensitize cells to 1,25(OH)₂D₃. Studies from our laboratory have demonstrated that mammary glands from VDR knockout (VDR KO) mice exhibit accelerated growth and branching during puberty, pregnancy and lactation as compared to wild-type (WT) mice. In addition, involution after weaning, a process driven by epithelial cell apoptosis, proceeds at a slower rate in VDR KO mice compared to WT mice. Using cells isolated from VDR KO and WT mice, we report that both normal and transformed mammary cells derived from WT mice are growth inhibited by 1,25(OH)₂D₃, however, cells derived from VDR KO mice are completely unresponsive to 1,25(OH)₂D₃. In human breast cancer cells, we have identified a variety of agents, including steroid hormones, phytoestrogens and growth factors, that up-regulate VDR expression and enhance sensitivity to 1,25(OH)₂D₃-mediated growth inhibition. Collectively, these studies support a role for 1,25(OH)₂D₃ and the VDR in negative growth regulation of both normal mammary gland and breast cancer cells.     

维生素D水平与牛奶蛋白过敏患儿的相关性研究

摘要 目的：探究维生素D水平与牛奶蛋白过敏（CMPA）患儿的相关性。方法：选取2018年6月~2020年6月就诊于我院的50例CMPA患儿作为观察组,根据其病情严重程度分为轻度组18例、中度组27例和重度组5例,另选取同期于本院进行健康体检的50例健康婴幼儿作为对照组。检测并比较各组血清25-羟基维生素D [25（OH）D]水平,收集婴幼儿的临床资料,采用单因素和多因素 Logistic 回归分析CMPA的相关影响因素。结果：观察组患儿血清25（OH）D水平显著低于对照组,差异具有统计学意义（P<0.05）;重度组和中度组患儿血清25（OH）D水平显著低于轻度组,而重度组又显著低于中度组,差异具有统计学意义（P<0.05）;单因素分析显示,CMPA与血清牛奶蛋白总免疫球蛋白E（IgE）检查结果、血嗜酸性粒细胞检查结果、家族过敏史、维生素D缺乏、喂养方式、生产方式有关（P<0.05）,多因素 Logistic 回归分析显示,血清牛奶蛋白总IgE为阳性、血嗜酸性粒细胞增多、家族过敏史、维生素D缺乏、人工喂养、剖宫产是CMPA的独立影响因素（P<0.05）。结论：CMPA患儿血清25（OH）D水平显著降低,且病情越严重,其水平越低,血清牛奶蛋白总IgE检查结果、血嗜酸性粒细胞检查结果、家族过敏史、维生素D缺乏、喂养方式、生产方式是CMPA的危险因素。